AuBiotech CEO Lorraine Chiroiu says the sector is very concerned by the decision to waive intellectual property protection for COVID-19 vaccines and treatments given what it says about the lack of understanding of its importance in attracting investment that ultimately supports innovation.
AusBiotech's Lorraine Chiroiu: A 'hollow victory' and 'slap in the face'
July 18, 2022 Latest NewsBioPharmaAustralian BiotechBioPharmaDispatch ExecutiveNews of the Day
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - 29 August
August 29, 2025 - - Podcast -
Government pressed on diabetes inquiry response as obesity costs soar
August 29, 2025 - - Latest News -
NDIS quarterly report presents a positive picture, but questions remain
August 29, 2025 - - Latest News -
Wesfarmers Health delivers growth as Priceline drives consumer momentum
August 29, 2025 - - Latest News -
'We can evade reality, but we cannot evade the consequences of evading reality'
August 29, 2025 - - Latest News -
Australians fear the loss of independence as vision health concerns rise
August 29, 2025 - - Latest News -
Coalition turns debate on cheaper medicines Bill to HTA reform delays
August 27, 2025 - - Latest News